BORDONARO, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 97
NA - Nord America 55
EU - Europa 24
SA - Sud America 4
AF - Africa 2
Totale 182
Nazione #
US - Stati Uniti d'America 52
SG - Singapore 38
CN - Cina 27
HK - Hong Kong 10
IT - Italia 10
VN - Vietnam 10
AT - Austria 5
ID - Indonesia 5
DE - Germania 4
FR - Francia 4
BR - Brasile 3
IN - India 3
CA - Canada 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AR - Argentina 1
FI - Finlandia 1
IQ - Iraq 1
KE - Kenya 1
MN - Mongolia 1
NI - Nicaragua 1
TR - Turchia 1
Totale 182
Città #
San Jose 17
Ashburn 10
Hong Kong 10
Singapore 9
Ho Chi Minh City 4
Turin 4
Vienna 4
Beijing 3
Bologna 2
Hanoi 2
Hillsboro 2
Ajman 1
Bandung 1
Banyuwangi 1
Chandigarh 1
Chennai 1
Denpasar 1
Frankfurt am Main 1
Garbagnate Milanese 1
Haiphong 1
Helsinki 1
Hải Dương 1
Inajá 1
Jakarta 1
Joinville 1
Luanda 1
Managua 1
Manassas 1
Mersin 1
Milan 1
Montreal 1
New York 1
Orem 1
Pune 1
Quảng Ngãi 1
Reston 1
Río Gallegos 1
Surabaya 1
São Paulo 1
Ulan Bator 1
Totale 96
Nome #
Implementation of a clinical governance model (UFA-ONCO-HEMA model) for anticancer drugs delivering and its adoption by a Regional Health Department 21
Activity and safety of CPBev regimen (Cis-platinum, Pemetrexed and Bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: final results of a phase II study. 18
THE ONCOLOGICAL SITUATION IN SICILY: PUBLIC AND PRIVARE STRUCTURES 16
Assessing awareness and knowledge of Human Papilloma virus infection in high school studente 15
PRELIMINARY DATA OF THE ASSOCIATION OF CIS-PLATINUM, PEMETREXED AND BEVACIZUMAB (CPBEV) AS FIRST-LINE THERAPY FOR LOCALLY ADVANCED OR METASTATIC ADENOCARCINOMA OF THE LUNG 14
Activity and safety of CPBev regimen (cisplatinum, pemetrexed, and bevacizumab) as first-line therapy for locally advanced or metastatic adenocarcinoma of the lung: Final results of a phase II study. 14
Preliminary study on financial toxicity perception among cancer patients: The financial toxicity questionnaire 16 13
A data collection representative of an outcome analysis in advanced Non Small Cell Lung Cancer (NSCLC) expressing EGFR mutations after failure of first line therapy with Tyrosine Kinase Inhibitors (TKIs) with careful on post progression survival 13
The clinical governance model (UFA-ONCO-EMA model) for anticancer drugs delivering of the ARNAS Garibaldi: third year experience 12
Drug-drug interaction between antineoplastic drug based protocols and general medications: a novel approach in the clinical practice 12
5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) plus Bevacizumab in patients with metastatic colo-rectal cancer (MCRC): a multicentric phase II trial 11
Pertuzumab, Trastuzumab, Docetaxel: a single istitution clinical exeperience for Her 2 positive metastatic breast cancer (mBC) 10
Tromboembolismo in oncologia medica 10
Second- and third-line chemotherapy in advanced gastric cancer: a real-life clinical picture. 10
Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire. 9
Totale 198
Categoria #
all - tutte 648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026198 0 0 0 18 39 52 12 37 23 17 0 0
Totale 198